Data from ProteomeXchange, PXD ID: PXD002034. File: Jiri_F_All.mgf. From ProteomeXchange: {{i}} SILAC analysis of fludarabine resistance in human Mino cells. {{/i}}
Ibrutinib, a bruton's tyrosine kinase inhibitor, was shown to have high response rates in mantle cell lymphoma (MCL), an aggressive B-cell lymphoma. However, emergence of ibrutinib resistance (IR) and
Ibrutinib, a bruton's tyrosine kinase inhibitor, was shown to have high response rates in mantle cell lymphoma (MCL), an aggressive B-cell lymphoma. However, emergence of ibrutinib resistance (IR) and